Ray Dalio’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.4M | Sell |
620,904
-70,196
| -10% | -$4.91M | 0.18% | 100 |
|
|
2025
Q1 | $50.8M | Buy |
691,100
+17,639
| +3% | +$1.3M | 0.24% | 87 |
|
|
2024
Q4 | $44.1M | Buy |
673,461
+468,353
| +228% | +$30.7M | 0.2% | 94 |
|
|
2024
Q3 | $16M | Sell |
205,108
-4,069
| -2% | -$317K | 0.09% | 185 |
|
|
2024
Q2 | $16.3M | Buy |
209,177
+109,915
| +111% | +$8.57M | 0.09% | 176 |
|
|
2024
Q1 | $6.73M | Sell |
99,262
-60,788
| -38% | -$4.12M | 0.03% | 327 |
|
|
2023
Q4 | $10.8M | Buy |
160,050
+46,241
| +41% | +$3.11M | 0.06% | 237 |
|
|
2023
Q3 | $7.71M | Buy |
113,809
+4,048
| +4% | +$274K | 0.05% | 276 |
|
|
2023
Q2 | $7.86M | Buy |
109,761
+12,149
| +12% | +$870K | 0.05% | 231 |
|
|
2023
Q1 | $6.78M | Buy |
97,612
+7,994
| +9% | +$555K | 0.04% | 258 |
|
|
2022
Q4 | $6.08M | Buy |
89,618
+9,827
| +12% | +$666K | 0.03% | 327 |
|
|
2022
Q3 | $4.38M | Buy |
79,791
+8,789
| +12% | +$482K | 0.02% | 412 |
|
|
2022
Q2 | $4.69M | Sell |
71,002
-5,584
| -7% | -$369K | 0.02% | 500 |
|
|
2022
Q1 | $5.08M | Buy |
76,586
+3,694
| +5% | +$245K | 0.02% | 466 |
|
|
2021
Q4 | $4.25M | Sell |
72,892
-31,341
| -30% | -$1.83M | 0.02% | 331 |
|
|
2021
Q3 | $6.26M | Buy |
104,233
+12,897
| +14% | +$775K | 0.03% | 262 |
|
|
2021
Q2 | $5.47M | Buy |
+91,336
| New | +$5.47M | 0.04% | 320 |
|